Korean Market
EXCH
ORGANOIDSCIENCES
★★

Organoid Sciences Enters 7.57B KRW Technology License Agreement with KRIBB - Strengthens IP for Regenerative Medicine and Drug Screening

 
MATR
ORGANOIDSCIENCES
★

Issuance of Convertible Bonds to 29 Funds - Put and Call Options Included

 
PERI
ORGANOIDSCIENCES
★

Organoid Sciences Q1 2026: Revenue Declines, Operating Loss Continues, ATORM-C Crohn's Disease Phase 1 IND Approved

 
EXCH
ORGANOIDSCIENCES
★

Completion of 24 billion won private placement convertible bond issuance

 
EXCH
ORGANOIDSCIENCES
★

Result of Issuance of Convertible Preferred Shares via Third-Party Allotment (KRW 5,999,851,752)

 
MATR
ORGANOIDSCIENCES
★

Organoid Sciences Decides on Third-Party Rights Offering - Issuance of Convertible Preferred Shares and Grant of Call Option